nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—SLC22A3—Progesterone—uterine cancer	0.213	0.262	CbGbCtD
Prazosin—SLC22A2—Progesterone—uterine cancer	0.126	0.155	CbGbCtD
Prazosin—SLC22A1—Progesterone—uterine cancer	0.109	0.135	CbGbCtD
Prazosin—CYP1A1—Progesterone—uterine cancer	0.0858	0.106	CbGbCtD
Prazosin—ABCG2—Dactinomycin—uterine cancer	0.0737	0.0907	CbGbCtD
Prazosin—ABCG2—Carboplatin—uterine cancer	0.0495	0.061	CbGbCtD
Prazosin—ABCG2—Etoposide—uterine cancer	0.0416	0.0512	CbGbCtD
Prazosin—ABCB1—Progesterone—uterine cancer	0.0335	0.0413	CbGbCtD
Prazosin—ABCG2—Doxorubicin—uterine cancer	0.0284	0.0349	CbGbCtD
Prazosin—ABCB1—Dactinomycin—uterine cancer	0.0266	0.0327	CbGbCtD
Prazosin—ABCB1—Etoposide—uterine cancer	0.015	0.0185	CbGbCtD
Prazosin—ABCB1—Doxorubicin—uterine cancer	0.0102	0.0126	CbGbCtD
Prazosin—HTR1D—artery—uterine cancer	0.00338	0.0495	CbGeAlD
Prazosin—KCNH6—renal system—uterine cancer	0.00287	0.042	CbGeAlD
Prazosin—KCNH6—uterus—uterine cancer	0.00255	0.0374	CbGeAlD
Prazosin—KCNH6—female reproductive system—uterine cancer	0.0023	0.0337	CbGeAlD
Prazosin—MT3—lymph node—uterine cancer	0.00189	0.0276	CbGeAlD
Prazosin—ADRA1D—epithelium—uterine cancer	0.00171	0.0251	CbGeAlD
Prazosin—SLC22A2—renal system—uterine cancer	0.0017	0.0249	CbGeAlD
Prazosin—Nasal congestion—Progesterone—uterine cancer	0.00167	0.0157	CcSEcCtD
Prazosin—ADRA1B—renal system—uterine cancer	0.00162	0.0238	CbGeAlD
Prazosin—SLC22A3—myometrium—uterine cancer	0.00157	0.0231	CbGeAlD
Prazosin—Sweating increased—Progesterone—uterine cancer	0.00128	0.012	CcSEcCtD
Prazosin—Angina pectoris—Progesterone—uterine cancer	0.00128	0.012	CcSEcCtD
Prazosin—ADRA1D—female reproductive system—uterine cancer	0.00127	0.0186	CbGeAlD
Prazosin—ORM1—endometrium—uterine cancer	0.00126	0.0185	CbGeAlD
Prazosin—Abdominal discomfort—Progesterone—uterine cancer	0.00126	0.0118	CcSEcCtD
Prazosin—Orthostatic hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.0118	CcSEcCtD
Prazosin—SLC22A3—uterine cervix—uterine cancer	0.00122	0.0179	CbGeAlD
Prazosin—Pain—Carboplatin—uterine cancer	0.00122	0.0114	CcSEcCtD
Prazosin—Pollakiuria—Progesterone—uterine cancer	0.00122	0.0114	CcSEcCtD
Prazosin—KCNH2—myometrium—uterine cancer	0.00121	0.0177	CbGeAlD
Prazosin—SLC22A1—renal system—uterine cancer	0.0012	0.0176	CbGeAlD
Prazosin—SLC22A3—smooth muscle tissue—uterine cancer	0.00119	0.0174	CbGeAlD
Prazosin—Drowsiness—Progesterone—uterine cancer	0.00117	0.011	CcSEcCtD
Prazosin—Sweating increased—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.0109	CcSEcCtD
Prazosin—SLC22A3—renal system—uterine cancer	0.00115	0.0168	CbGeAlD
Prazosin—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.0107	CcSEcCtD
Prazosin—Body temperature increased—Carboplatin—uterine cancer	0.00113	0.0106	CcSEcCtD
Prazosin—SLC22A3—endometrium—uterine cancer	0.00111	0.0162	CbGeAlD
Prazosin—Pollakiuria—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.0103	CcSEcCtD
Prazosin—ABCG2—myometrium—uterine cancer	0.00108	0.0158	CbGeAlD
Prazosin—SLC22A3—mammalian vulva—uterine cancer	0.00107	0.0157	CbGeAlD
Prazosin—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00998	CcSEcCtD
Prazosin—ORM1—female reproductive system—uterine cancer	0.00105	0.0154	CbGeAlD
Prazosin—Epistaxis—Medroxyprogesterone Acetate—uterine cancer	0.001	0.00941	CcSEcCtD
Prazosin—HTR1A—renal system—uterine cancer	0.00099	0.0145	CbGeAlD
Prazosin—ADRA1A—epithelium—uterine cancer	0.000984	0.0144	CbGeAlD
Prazosin—Tinnitus—Progesterone—uterine cancer	0.000983	0.00922	CcSEcCtD
Prazosin—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.000972	0.00912	CcSEcCtD
Prazosin—ADRA2A—myometrium—uterine cancer	0.000953	0.014	CbGeAlD
Prazosin—HTR1D—female reproductive system—uterine cancer	0.000951	0.0139	CbGeAlD
Prazosin—KCNH2—uterine cervix—uterine cancer	0.000942	0.0138	CbGeAlD
Prazosin—Alopecia—Progesterone—uterine cancer	0.000932	0.00874	CcSEcCtD
Prazosin—SLC22A3—female reproductive system—uterine cancer	0.000917	0.0134	CbGeAlD
Prazosin—ADRA1A—renal system—uterine cancer	0.000912	0.0134	CbGeAlD
Prazosin—Tension—Progesterone—uterine cancer	0.000901	0.00844	CcSEcCtD
Prazosin—Nervousness—Progesterone—uterine cancer	0.000891	0.00836	CcSEcCtD
Prazosin—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.000891	0.00835	CcSEcCtD
Prazosin—KCNH2—renal system—uterine cancer	0.000881	0.0129	CbGeAlD
Prazosin—SLC22A1—vagina—uterine cancer	0.000868	0.0127	CbGeAlD
Prazosin—Vision blurred—Progesterone—uterine cancer	0.000865	0.00811	CcSEcCtD
Prazosin—KCNH2—endometrium—uterine cancer	0.000852	0.0125	CbGeAlD
Prazosin—Ill-defined disorder—Progesterone—uterine cancer	0.000851	0.00798	CcSEcCtD
Prazosin—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.000844	0.00792	CcSEcCtD
Prazosin—ABCG2—uterine cervix—uterine cancer	0.000838	0.0123	CbGeAlD
Prazosin—SLC22A3—female gonad—uterine cancer	0.000835	0.0122	CbGeAlD
Prazosin—SLC22A3—vagina—uterine cancer	0.000829	0.0122	CbGeAlD
Prazosin—Malaise—Progesterone—uterine cancer	0.000828	0.00776	CcSEcCtD
Prazosin—Vertigo—Progesterone—uterine cancer	0.000824	0.00773	CcSEcCtD
Prazosin—Syncope—Progesterone—uterine cancer	0.000823	0.00772	CcSEcCtD
Prazosin—Tension—Medroxyprogesterone Acetate—uterine cancer	0.000816	0.00765	CcSEcCtD
Prazosin—Palpitations—Progesterone—uterine cancer	0.000811	0.0076	CcSEcCtD
Prazosin—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.000808	0.00757	CcSEcCtD
Prazosin—Loss of consciousness—Progesterone—uterine cancer	0.000807	0.00756	CcSEcCtD
Prazosin—CYP1A1—epithelium—uterine cancer	0.000802	0.0118	CbGeAlD
Prazosin—ABCG2—decidua—uterine cancer	0.000798	0.0117	CbGeAlD
Prazosin—CYP1A1—uterine cervix—uterine cancer	0.000795	0.0117	CbGeAlD
Prazosin—KCNH2—uterus—uterine cancer	0.000785	0.0115	CbGeAlD
Prazosin—Arthralgia—Progesterone—uterine cancer	0.000781	0.00733	CcSEcCtD
Prazosin—Discomfort—Progesterone—uterine cancer	0.000772	0.00724	CcSEcCtD
Prazosin—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.000772	0.00724	CcSEcCtD
Prazosin—Dry mouth—Progesterone—uterine cancer	0.000764	0.00717	CcSEcCtD
Prazosin—ABCG2—endometrium—uterine cancer	0.000758	0.0111	CbGeAlD
Prazosin—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00075	0.00703	CcSEcCtD
Prazosin—Oedema—Progesterone—uterine cancer	0.000749	0.00702	CcSEcCtD
Prazosin—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.000747	0.00701	CcSEcCtD
Prazosin—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.000746	0.00699	CcSEcCtD
Prazosin—CYP1A1—renal system—uterine cancer	0.000744	0.0109	CbGeAlD
Prazosin—ADRA2A—uterine cervix—uterine cancer	0.000741	0.0109	CbGeAlD
Prazosin—Shock—Progesterone—uterine cancer	0.000737	0.00691	CcSEcCtD
Prazosin—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.000735	0.00689	CcSEcCtD
Prazosin—ABCG2—mammalian vulva—uterine cancer	0.000733	0.0107	CbGeAlD
Prazosin—Tachycardia—Progesterone—uterine cancer	0.000731	0.00685	CcSEcCtD
Prazosin—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.000731	0.00685	CcSEcCtD
Prazosin—Hyperhidrosis—Progesterone—uterine cancer	0.000724	0.00679	CcSEcCtD
Prazosin—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.000708	0.00664	CcSEcCtD
Prazosin—ADRA2A—decidua—uterine cancer	0.000706	0.0104	CbGeAlD
Prazosin—KCNH2—female reproductive system—uterine cancer	0.000706	0.0103	CbGeAlD
Prazosin—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000699	0.00656	CcSEcCtD
Prazosin—ABCG2—uterus—uterine cancer	0.000698	0.0102	CbGeAlD
Prazosin—CYP1A1—mammalian vulva—uterine cancer	0.000696	0.0102	CbGeAlD
Prazosin—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000692	0.00649	CcSEcCtD
Prazosin—Flushing—Dactinomycin—uterine cancer	0.000692	0.00648	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000682	0.0064	CcSEcCtD
Prazosin—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000679	0.00636	CcSEcCtD
Prazosin—Insomnia—Progesterone—uterine cancer	0.000677	0.00635	CcSEcCtD
Prazosin—Paraesthesia—Progesterone—uterine cancer	0.000673	0.00631	CcSEcCtD
Prazosin—ADRA2A—endometrium—uterine cancer	0.000671	0.00983	CbGeAlD
Prazosin—Dyspnoea—Progesterone—uterine cancer	0.000668	0.00626	CcSEcCtD
Prazosin—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000668	0.00626	CcSEcCtD
Prazosin—Somnolence—Progesterone—uterine cancer	0.000666	0.00624	CcSEcCtD
Prazosin—CYP1A1—uterus—uterine cancer	0.000663	0.00972	CbGeAlD
Prazosin—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000662	0.00621	CcSEcCtD
Prazosin—Alopecia—Dactinomycin—uterine cancer	0.000658	0.00617	CcSEcCtD
Prazosin—Sweating increased—Etoposide—uterine cancer	0.000656	0.00615	CcSEcCtD
Prazosin—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000656	0.00615	CcSEcCtD
Prazosin—ADRA2A—mammalian vulva—uterine cancer	0.000649	0.00951	CbGeAlD
Prazosin—Fatigue—Progesterone—uterine cancer	0.000646	0.00606	CcSEcCtD
Prazosin—KCNH2—female gonad—uterine cancer	0.000642	0.00941	CbGeAlD
Prazosin—Constipation—Progesterone—uterine cancer	0.00064	0.00601	CcSEcCtD
Prazosin—Pain—Progesterone—uterine cancer	0.00064	0.00601	CcSEcCtD
Prazosin—KCNH2—vagina—uterine cancer	0.000638	0.00935	CbGeAlD
Prazosin—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000618	0.0058	CcSEcCtD
Prazosin—ADRA2A—uterus—uterine cancer	0.000618	0.00906	CbGeAlD
Prazosin—Feeling abnormal—Progesterone—uterine cancer	0.000617	0.00579	CcSEcCtD
Prazosin—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000614	0.00576	CcSEcCtD
Prazosin—ORM1—lymph node—uterine cancer	0.000613	0.00898	CbGeAlD
Prazosin—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000609	0.00571	CcSEcCtD
Prazosin—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000605	0.00567	CcSEcCtD
Prazosin—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000603	0.00566	CcSEcCtD
Prazosin—Ill-defined disorder—Dactinomycin—uterine cancer	0.000602	0.00564	CcSEcCtD
Prazosin—CYP1A1—female reproductive system—uterine cancer	0.000596	0.00873	CbGeAlD
Prazosin—Urticaria—Progesterone—uterine cancer	0.000595	0.00558	CcSEcCtD
Prazosin—Body temperature increased—Progesterone—uterine cancer	0.000592	0.00555	CcSEcCtD
Prazosin—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000585	0.00549	CcSEcCtD
Prazosin—Malaise—Dactinomycin—uterine cancer	0.000585	0.00549	CcSEcCtD
Prazosin—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00058	0.00544	CcSEcCtD
Prazosin—ABCG2—female gonad—uterine cancer	0.000571	0.00837	CbGeAlD
Prazosin—ABCG2—vagina—uterine cancer	0.000568	0.00832	CbGeAlD
Prazosin—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000559	0.00524	CcSEcCtD
Prazosin—ADRA2A—female reproductive system—uterine cancer	0.000556	0.00814	CbGeAlD
Prazosin—Hypersensitivity—Progesterone—uterine cancer	0.000552	0.00517	CcSEcCtD
Prazosin—Discomfort—Dactinomycin—uterine cancer	0.000546	0.00512	CcSEcCtD
Prazosin—CYP1A1—female gonad—uterine cancer	0.000542	0.00795	CbGeAlD
Prazosin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000539	0.00506	CcSEcCtD
Prazosin—CYP1A1—vagina—uterine cancer	0.000539	0.0079	CbGeAlD
Prazosin—Asthenia—Progesterone—uterine cancer	0.000537	0.00504	CcSEcCtD
Prazosin—SLC22A3—lymph node—uterine cancer	0.000537	0.00786	CbGeAlD
Prazosin—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000536	0.00503	CcSEcCtD
Prazosin—ABCB1—myometrium—uterine cancer	0.000531	0.00778	CbGeAlD
Prazosin—Pruritus—Progesterone—uterine cancer	0.00053	0.00497	CcSEcCtD
Prazosin—Oedema—Dactinomycin—uterine cancer	0.000529	0.00496	CcSEcCtD
Prazosin—Diarrhoea—Progesterone—uterine cancer	0.000512	0.00481	CcSEcCtD
Prazosin—ADRA2A—female gonad—uterine cancer	0.000505	0.00741	CbGeAlD
Prazosin—ADRA2A—vagina—uterine cancer	0.000502	0.00736	CbGeAlD
Prazosin—Flushing—Etoposide—uterine cancer	0.0005	0.00469	CcSEcCtD
Prazosin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.0005	0.00469	CcSEcCtD
Prazosin—Dizziness—Progesterone—uterine cancer	0.000495	0.00464	CcSEcCtD
Prazosin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000487	0.00457	CcSEcCtD
Prazosin—Eye pain—Epirubicin—uterine cancer	0.000484	0.00454	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000482	0.00452	CcSEcCtD
Prazosin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00048	0.0045	CcSEcCtD
Prazosin—Alopecia—Etoposide—uterine cancer	0.000477	0.00447	CcSEcCtD
Prazosin—Vomiting—Progesterone—uterine cancer	0.000476	0.00447	CcSEcCtD
Prazosin—Rash—Progesterone—uterine cancer	0.000472	0.00443	CcSEcCtD
Prazosin—Dermatitis—Progesterone—uterine cancer	0.000472	0.00442	CcSEcCtD
Prazosin—Headache—Progesterone—uterine cancer	0.000469	0.0044	CcSEcCtD
Prazosin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000464	0.00435	CcSEcCtD
Prazosin—Fatigue—Dactinomycin—uterine cancer	0.000456	0.00428	CcSEcCtD
Prazosin—Pain—Dactinomycin—uterine cancer	0.000453	0.00425	CcSEcCtD
Prazosin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000449	0.00421	CcSEcCtD
Prazosin—Eye pain—Doxorubicin—uterine cancer	0.000448	0.0042	CcSEcCtD
Prazosin—Nausea—Progesterone—uterine cancer	0.000445	0.00417	CcSEcCtD
Prazosin—Feeling abnormal—Dactinomycin—uterine cancer	0.000436	0.00409	CcSEcCtD
Prazosin—Ill-defined disorder—Etoposide—uterine cancer	0.000436	0.00408	CcSEcCtD
Prazosin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000432	0.00405	CcSEcCtD
Prazosin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000428	0.00401	CcSEcCtD
Prazosin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000428	0.00401	CcSEcCtD
Prazosin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000425	0.00399	CcSEcCtD
Prazosin—Malaise—Etoposide—uterine cancer	0.000423	0.00397	CcSEcCtD
Prazosin—Vertigo—Etoposide—uterine cancer	0.000422	0.00396	CcSEcCtD
Prazosin—Body temperature increased—Dactinomycin—uterine cancer	0.000418	0.00392	CcSEcCtD
Prazosin—ABCB1—epithelium—uterine cancer	0.000417	0.00611	CbGeAlD
Prazosin—ABCB1—uterine cervix—uterine cancer	0.000413	0.00605	CbGeAlD
Prazosin—KCNH2—lymph node—uterine cancer	0.000413	0.00605	CbGeAlD
Prazosin—Loss of consciousness—Etoposide—uterine cancer	0.000413	0.00387	CcSEcCtD
Prazosin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000403	0.00378	CcSEcCtD
Prazosin—Orthostatic hypotension—Epirubicin—uterine cancer	0.000399	0.00374	CcSEcCtD
Prazosin—Discomfort—Etoposide—uterine cancer	0.000395	0.0037	CcSEcCtD
Prazosin—ABCB1—decidua—uterine cancer	0.000394	0.00577	CbGeAlD
Prazosin—Hypersensitivity—Dactinomycin—uterine cancer	0.00039	0.00366	CcSEcCtD
Prazosin—ABCB1—renal system—uterine cancer	0.000387	0.00566	CbGeAlD
Prazosin—Asthenia—Dactinomycin—uterine cancer	0.00038	0.00356	CcSEcCtD
Prazosin—Tachycardia—Etoposide—uterine cancer	0.000374	0.00351	CcSEcCtD
Prazosin—ABCB1—endometrium—uterine cancer	0.000374	0.00548	CbGeAlD
Prazosin—Hyperhidrosis—Etoposide—uterine cancer	0.00037	0.00347	CcSEcCtD
Prazosin—Pancreatitis—Epirubicin—uterine cancer	0.00037	0.00347	CcSEcCtD
Prazosin—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000369	0.00346	CcSEcCtD
Prazosin—Angina pectoris—Epirubicin—uterine cancer	0.000368	0.00345	CcSEcCtD
Prazosin—ABCG2—lymph node—uterine cancer	0.000367	0.00538	CbGeAlD
Prazosin—Diarrhoea—Dactinomycin—uterine cancer	0.000362	0.0034	CcSEcCtD
Prazosin—ABCB1—mammalian vulva—uterine cancer	0.000361	0.0053	CbGeAlD
Prazosin—Pollakiuria—Epirubicin—uterine cancer	0.000349	0.00327	CcSEcCtD
Prazosin—CYP1A1—lymph node—uterine cancer	0.000349	0.00511	CbGeAlD
Prazosin—ABCB1—uterus—uterine cancer	0.000344	0.00505	CbGeAlD
Prazosin—Paraesthesia—Etoposide—uterine cancer	0.000344	0.00323	CcSEcCtD
Prazosin—Pancreatitis—Doxorubicin—uterine cancer	0.000343	0.00321	CcSEcCtD
Prazosin—Dyspnoea—Etoposide—uterine cancer	0.000342	0.0032	CcSEcCtD
Prazosin—Somnolence—Etoposide—uterine cancer	0.000341	0.00319	CcSEcCtD
Prazosin—Angina pectoris—Doxorubicin—uterine cancer	0.00034	0.00319	CcSEcCtD
Prazosin—Drowsiness—Epirubicin—uterine cancer	0.000337	0.00316	CcSEcCtD
Prazosin—Vomiting—Dactinomycin—uterine cancer	0.000337	0.00316	CcSEcCtD
Prazosin—Rash—Dactinomycin—uterine cancer	0.000334	0.00313	CcSEcCtD
Prazosin—Fatigue—Etoposide—uterine cancer	0.00033	0.0031	CcSEcCtD
Prazosin—Pain—Etoposide—uterine cancer	0.000328	0.00307	CcSEcCtD
Prazosin—Constipation—Etoposide—uterine cancer	0.000328	0.00307	CcSEcCtD
Prazosin—ADRA2A—lymph node—uterine cancer	0.000325	0.00476	CbGeAlD
Prazosin—Pollakiuria—Doxorubicin—uterine cancer	0.000323	0.00303	CcSEcCtD
Prazosin—Epistaxis—Epirubicin—uterine cancer	0.000318	0.00298	CcSEcCtD
Prazosin—Feeling abnormal—Etoposide—uterine cancer	0.000316	0.00296	CcSEcCtD
Prazosin—Nausea—Dactinomycin—uterine cancer	0.000314	0.00295	CcSEcCtD
Prazosin—Drowsiness—Doxorubicin—uterine cancer	0.000312	0.00292	CcSEcCtD
Prazosin—ABCB1—female reproductive system—uterine cancer	0.00031	0.00454	CbGeAlD
Prazosin—Bradycardia—Epirubicin—uterine cancer	0.000308	0.00289	CcSEcCtD
Prazosin—Urticaria—Etoposide—uterine cancer	0.000304	0.00285	CcSEcCtD
Prazosin—Body temperature increased—Etoposide—uterine cancer	0.000303	0.00284	CcSEcCtD
Prazosin—Epistaxis—Doxorubicin—uterine cancer	0.000294	0.00276	CcSEcCtD
Prazosin—Bradycardia—Doxorubicin—uterine cancer	0.000285	0.00267	CcSEcCtD
Prazosin—Hypersensitivity—Etoposide—uterine cancer	0.000282	0.00265	CcSEcCtD
Prazosin—Tinnitus—Epirubicin—uterine cancer	0.000282	0.00264	CcSEcCtD
Prazosin—ABCB1—female gonad—uterine cancer	0.000282	0.00413	CbGeAlD
Prazosin—Flushing—Epirubicin—uterine cancer	0.000281	0.00263	CcSEcCtD
Prazosin—ABCB1—vagina—uterine cancer	0.00028	0.0041	CbGeAlD
Prazosin—Asthenia—Etoposide—uterine cancer	0.000275	0.00258	CcSEcCtD
Prazosin—Pruritus—Etoposide—uterine cancer	0.000271	0.00254	CcSEcCtD
Prazosin—Alopecia—Epirubicin—uterine cancer	0.000267	0.0025	CcSEcCtD
Prazosin—Diarrhoea—Etoposide—uterine cancer	0.000262	0.00246	CcSEcCtD
Prazosin—Tinnitus—Doxorubicin—uterine cancer	0.000261	0.00245	CcSEcCtD
Prazosin—Flushing—Doxorubicin—uterine cancer	0.00026	0.00243	CcSEcCtD
Prazosin—Tension—Epirubicin—uterine cancer	0.000258	0.00242	CcSEcCtD
Prazosin—Nervousness—Epirubicin—uterine cancer	0.000256	0.0024	CcSEcCtD
Prazosin—Dizziness—Etoposide—uterine cancer	0.000253	0.00238	CcSEcCtD
Prazosin—Vision blurred—Epirubicin—uterine cancer	0.000248	0.00233	CcSEcCtD
Prazosin—Alopecia—Doxorubicin—uterine cancer	0.000247	0.00232	CcSEcCtD
Prazosin—Ill-defined disorder—Epirubicin—uterine cancer	0.000244	0.00229	CcSEcCtD
Prazosin—Vomiting—Etoposide—uterine cancer	0.000244	0.00228	CcSEcCtD
Prazosin—Rash—Etoposide—uterine cancer	0.000242	0.00227	CcSEcCtD
Prazosin—Dermatitis—Etoposide—uterine cancer	0.000241	0.00226	CcSEcCtD
Prazosin—Headache—Etoposide—uterine cancer	0.00024	0.00225	CcSEcCtD
Prazosin—Tension—Doxorubicin—uterine cancer	0.000239	0.00224	CcSEcCtD
Prazosin—Malaise—Epirubicin—uterine cancer	0.000237	0.00223	CcSEcCtD
Prazosin—Nervousness—Doxorubicin—uterine cancer	0.000236	0.00222	CcSEcCtD
Prazosin—Vertigo—Epirubicin—uterine cancer	0.000236	0.00222	CcSEcCtD
Prazosin—Syncope—Epirubicin—uterine cancer	0.000236	0.00221	CcSEcCtD
Prazosin—Palpitations—Epirubicin—uterine cancer	0.000233	0.00218	CcSEcCtD
Prazosin—Loss of consciousness—Epirubicin—uterine cancer	0.000231	0.00217	CcSEcCtD
Prazosin—Vision blurred—Doxorubicin—uterine cancer	0.000229	0.00215	CcSEcCtD
Prazosin—Nausea—Etoposide—uterine cancer	0.000228	0.00213	CcSEcCtD
Prazosin—Ill-defined disorder—Doxorubicin—uterine cancer	0.000226	0.00212	CcSEcCtD
Prazosin—Arthralgia—Epirubicin—uterine cancer	0.000224	0.0021	CcSEcCtD
Prazosin—Discomfort—Epirubicin—uterine cancer	0.000221	0.00208	CcSEcCtD
Prazosin—Malaise—Doxorubicin—uterine cancer	0.00022	0.00206	CcSEcCtD
Prazosin—Dry mouth—Epirubicin—uterine cancer	0.000219	0.00205	CcSEcCtD
Prazosin—Vertigo—Doxorubicin—uterine cancer	0.000219	0.00205	CcSEcCtD
Prazosin—Syncope—Doxorubicin—uterine cancer	0.000218	0.00205	CcSEcCtD
Prazosin—Palpitations—Doxorubicin—uterine cancer	0.000215	0.00202	CcSEcCtD
Prazosin—Oedema—Epirubicin—uterine cancer	0.000215	0.00201	CcSEcCtD
Prazosin—Loss of consciousness—Doxorubicin—uterine cancer	0.000214	0.00201	CcSEcCtD
Prazosin—Shock—Epirubicin—uterine cancer	0.000211	0.00198	CcSEcCtD
Prazosin—Tachycardia—Epirubicin—uterine cancer	0.00021	0.00197	CcSEcCtD
Prazosin—Hyperhidrosis—Epirubicin—uterine cancer	0.000208	0.00195	CcSEcCtD
Prazosin—Arthralgia—Doxorubicin—uterine cancer	0.000207	0.00194	CcSEcCtD
Prazosin—Discomfort—Doxorubicin—uterine cancer	0.000205	0.00192	CcSEcCtD
Prazosin—Dry mouth—Doxorubicin—uterine cancer	0.000203	0.0019	CcSEcCtD
Prazosin—Oedema—Doxorubicin—uterine cancer	0.000199	0.00186	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000196	0.00183	CcSEcCtD
Prazosin—Shock—Doxorubicin—uterine cancer	0.000196	0.00183	CcSEcCtD
Prazosin—Insomnia—Epirubicin—uterine cancer	0.000194	0.00182	CcSEcCtD
Prazosin—Tachycardia—Doxorubicin—uterine cancer	0.000194	0.00182	CcSEcCtD
Prazosin—Paraesthesia—Epirubicin—uterine cancer	0.000193	0.00181	CcSEcCtD
Prazosin—Hyperhidrosis—Doxorubicin—uterine cancer	0.000192	0.0018	CcSEcCtD
Prazosin—Dyspnoea—Epirubicin—uterine cancer	0.000191	0.0018	CcSEcCtD
Prazosin—Somnolence—Epirubicin—uterine cancer	0.000191	0.00179	CcSEcCtD
Prazosin—Fatigue—Epirubicin—uterine cancer	0.000185	0.00174	CcSEcCtD
Prazosin—Constipation—Epirubicin—uterine cancer	0.000184	0.00172	CcSEcCtD
Prazosin—Pain—Epirubicin—uterine cancer	0.000184	0.00172	CcSEcCtD
Prazosin—ABCB1—lymph node—uterine cancer	0.000181	0.00265	CbGeAlD
Prazosin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000181	0.0017	CcSEcCtD
Prazosin—Insomnia—Doxorubicin—uterine cancer	0.00018	0.00169	CcSEcCtD
Prazosin—Paraesthesia—Doxorubicin—uterine cancer	0.000178	0.00167	CcSEcCtD
Prazosin—Dyspnoea—Doxorubicin—uterine cancer	0.000177	0.00166	CcSEcCtD
Prazosin—Feeling abnormal—Epirubicin—uterine cancer	0.000177	0.00166	CcSEcCtD
Prazosin—Somnolence—Doxorubicin—uterine cancer	0.000177	0.00166	CcSEcCtD
Prazosin—Fatigue—Doxorubicin—uterine cancer	0.000171	0.00161	CcSEcCtD
Prazosin—Urticaria—Epirubicin—uterine cancer	0.000171	0.0016	CcSEcCtD
Prazosin—Pain—Doxorubicin—uterine cancer	0.00017	0.00159	CcSEcCtD
Prazosin—Constipation—Doxorubicin—uterine cancer	0.00017	0.00159	CcSEcCtD
Prazosin—Body temperature increased—Epirubicin—uterine cancer	0.00017	0.00159	CcSEcCtD
Prazosin—Feeling abnormal—Doxorubicin—uterine cancer	0.000164	0.00154	CcSEcCtD
Prazosin—Hypersensitivity—Epirubicin—uterine cancer	0.000158	0.00148	CcSEcCtD
Prazosin—Urticaria—Doxorubicin—uterine cancer	0.000158	0.00148	CcSEcCtD
Prazosin—Body temperature increased—Doxorubicin—uterine cancer	0.000157	0.00147	CcSEcCtD
Prazosin—Asthenia—Epirubicin—uterine cancer	0.000154	0.00144	CcSEcCtD
Prazosin—Pruritus—Epirubicin—uterine cancer	0.000152	0.00142	CcSEcCtD
Prazosin—Diarrhoea—Epirubicin—uterine cancer	0.000147	0.00138	CcSEcCtD
Prazosin—Hypersensitivity—Doxorubicin—uterine cancer	0.000146	0.00137	CcSEcCtD
Prazosin—Asthenia—Doxorubicin—uterine cancer	0.000143	0.00134	CcSEcCtD
Prazosin—Dizziness—Epirubicin—uterine cancer	0.000142	0.00133	CcSEcCtD
Prazosin—Pruritus—Doxorubicin—uterine cancer	0.000141	0.00132	CcSEcCtD
Prazosin—Vomiting—Epirubicin—uterine cancer	0.000137	0.00128	CcSEcCtD
Prazosin—Diarrhoea—Doxorubicin—uterine cancer	0.000136	0.00127	CcSEcCtD
Prazosin—Rash—Epirubicin—uterine cancer	0.000135	0.00127	CcSEcCtD
Prazosin—Dermatitis—Epirubicin—uterine cancer	0.000135	0.00127	CcSEcCtD
Prazosin—Headache—Epirubicin—uterine cancer	0.000135	0.00126	CcSEcCtD
Prazosin—Dizziness—Doxorubicin—uterine cancer	0.000131	0.00123	CcSEcCtD
Prazosin—Nausea—Epirubicin—uterine cancer	0.000128	0.0012	CcSEcCtD
Prazosin—Vomiting—Doxorubicin—uterine cancer	0.000126	0.00118	CcSEcCtD
Prazosin—Rash—Doxorubicin—uterine cancer	0.000125	0.00117	CcSEcCtD
Prazosin—Dermatitis—Doxorubicin—uterine cancer	0.000125	0.00117	CcSEcCtD
Prazosin—Headache—Doxorubicin—uterine cancer	0.000124	0.00117	CcSEcCtD
Prazosin—Nausea—Doxorubicin—uterine cancer	0.000118	0.00111	CcSEcCtD
Prazosin—ADRA2B—Signaling Pathways—CDKN2B—uterine cancer	5.27e-06	0.000405	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—EP300—uterine cancer	5.25e-06	0.000403	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—MTHFR—uterine cancer	5.13e-06	0.000394	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—CXCL8—uterine cancer	5.13e-06	0.000394	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IGF1R—uterine cancer	5.12e-06	0.000394	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—PIK3CA—uterine cancer	5.11e-06	0.000393	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—FBXW7—uterine cancer	5.1e-06	0.000392	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—CXCL8—uterine cancer	5.1e-06	0.000392	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CDKN2B—uterine cancer	5.09e-06	0.000391	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—FGFR2—uterine cancer	5.08e-06	0.000391	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—ESR1—uterine cancer	5.08e-06	0.000391	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—MTHFR—uterine cancer	5.07e-06	0.00039	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—SOCS3—uterine cancer	5.06e-06	0.000389	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CYP11A1—uterine cancer	5.01e-06	0.000386	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—VEGFA—uterine cancer	4.97e-06	0.000382	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—TP53—uterine cancer	4.95e-06	0.000381	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IGF1R—uterine cancer	4.94e-06	0.00038	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—CXCL8—uterine cancer	4.92e-06	0.000378	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—NRAS—uterine cancer	4.91e-06	0.000377	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CDKN2B—uterine cancer	4.85e-06	0.000373	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—SMAD3—uterine cancer	4.81e-06	0.00037	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—NRAS—uterine cancer	4.8e-06	0.000369	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—STK11—uterine cancer	4.8e-06	0.000369	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	4.78e-06	0.000368	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CCL2—uterine cancer	4.78e-06	0.000368	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—AKR1C3—uterine cancer	4.74e-06	0.000364	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—HRAS—uterine cancer	4.73e-06	0.000364	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—MTHFR—uterine cancer	4.73e-06	0.000364	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IGF1R—uterine cancer	4.71e-06	0.000362	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—CXCL8—uterine cancer	4.68e-06	0.00036	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—SMAD3—uterine cancer	4.65e-06	0.000357	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—CXCL8—uterine cancer	4.63e-06	0.000356	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—CYP19A1—uterine cancer	4.62e-06	0.000355	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—STK11—uterine cancer	4.62e-06	0.000355	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—FGFR2—uterine cancer	4.59e-06	0.000353	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—PTEN—uterine cancer	4.5e-06	0.000346	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—SOCS3—uterine cancer	4.5e-06	0.000346	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CCL2—uterine cancer	4.47e-06	0.000344	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—CXCL8—uterine cancer	4.47e-06	0.000344	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—STK11—uterine cancer	4.46e-06	0.000343	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CCL2—uterine cancer	4.44e-06	0.000342	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—FGFR2—uterine cancer	4.43e-06	0.000341	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—SMAD3—uterine cancer	4.42e-06	0.00034	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—ESR1—uterine cancer	4.35e-06	0.000335	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.34e-06	0.000333	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CDKN2B—uterine cancer	4.3e-06	0.000331	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—EP300—uterine cancer	4.29e-06	0.00033	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—CXCL8—uterine cancer	4.25e-06	0.000327	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—KRAS—uterine cancer	4.22e-06	0.000325	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—FGFR2—uterine cancer	4.22e-06	0.000325	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—PIK3CA—uterine cancer	4.18e-06	0.000322	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IGF1R—uterine cancer	4.18e-06	0.000321	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—AKT1—uterine cancer	4.18e-06	0.000321	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—SOCS3—uterine cancer	4.18e-06	0.000321	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—CXCL8—uterine cancer	4.16e-06	0.00032	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—KRAS—uterine cancer	4.14e-06	0.000318	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.13e-06	0.000318	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—NRAS—uterine cancer	4.11e-06	0.000316	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—MTHFR—uterine cancer	4.01e-06	0.000308	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CDKN2B—uterine cancer	4e-06	0.000308	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—SMAD3—uterine cancer	3.93e-06	0.000302	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—ESR1—uterine cancer	3.93e-06	0.000302	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IGF1R—uterine cancer	3.88e-06	0.000299	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—PIK3CA—uterine cancer	3.88e-06	0.000298	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—CXCL8—uterine cancer	3.87e-06	0.000297	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CCL2—uterine cancer	3.83e-06	0.000295	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—PIK3CA—uterine cancer	3.8e-06	0.000292	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—ESR1—uterine cancer	3.79e-06	0.000292	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CXCL8—uterine cancer	3.78e-06	0.000291	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—TP53—uterine cancer	3.75e-06	0.000289	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—FGFR2—uterine cancer	3.75e-06	0.000288	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—ERBB2—uterine cancer	3.73e-06	0.000287	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—NRAS—uterine cancer	3.71e-06	0.000285	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—STK11—uterine cancer	3.69e-06	0.000284	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CYP19A1—uterine cancer	3.69e-06	0.000284	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—SMAD3—uterine cancer	3.65e-06	0.000281	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—ESR1—uterine cancer	3.61e-06	0.000278	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—HRAS—uterine cancer	3.59e-06	0.000276	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—NRAS—uterine cancer	3.58e-06	0.000276	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—PIK3CA—uterine cancer	3.58e-06	0.000275	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—KRAS—uterine cancer	3.54e-06	0.000272	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CXCL8—uterine cancer	3.54e-06	0.000272	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—HRAS—uterine cancer	3.51e-06	0.00027	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CXCL8—uterine cancer	3.51e-06	0.00027	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—FGFR2—uterine cancer	3.48e-06	0.000268	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—MTHFR—uterine cancer	3.47e-06	0.000267	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCL2—uterine cancer	3.46e-06	0.000266	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CDKN1B—uterine cancer	3.45e-06	0.000266	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—AKT1—uterine cancer	3.42e-06	0.000263	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—NRAS—uterine cancer	3.41e-06	0.000262	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCL2—uterine cancer	3.34e-06	0.000257	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CTNNB1—uterine cancer	3.26e-06	0.000251	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—PIK3CA—uterine cancer	3.25e-06	0.00025	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—PIK3CA—uterine cancer	3.23e-06	0.000249	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ESR1—uterine cancer	3.21e-06	0.000247	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—KRAS—uterine cancer	3.2e-06	0.000246	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—ERBB2—uterine cancer	3.19e-06	0.000246	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—PTEN—uterine cancer	3.18e-06	0.000245	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCL2—uterine cancer	3.18e-06	0.000244	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—PIK3CA—uterine cancer	3.18e-06	0.000244	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—AKT1—uterine cancer	3.17e-06	0.000244	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—PIK3CA—uterine cancer	3.12e-06	0.00024	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—AKT1—uterine cancer	3.1e-06	0.000239	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—KRAS—uterine cancer	3.08e-06	0.000237	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.06e-06	0.000235	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—EP300—uterine cancer	3.03e-06	0.000233	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—NRAS—uterine cancer	3.03e-06	0.000233	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CXCL8—uterine cancer	3.03e-06	0.000233	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—HRAS—uterine cancer	3.01e-06	0.000231	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ESR1—uterine cancer	2.98e-06	0.000229	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—PIK3CA—uterine cancer	2.97e-06	0.000229	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CDKN1B—uterine cancer	2.96e-06	0.000227	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—KRAS—uterine cancer	2.94e-06	0.000226	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—PIK3CA—uterine cancer	2.94e-06	0.000226	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—AKT1—uterine cancer	2.92e-06	0.000225	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—ERBB2—uterine cancer	2.88e-06	0.000222	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—VEGFA—uterine cancer	2.87e-06	0.000221	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—PTEN—uterine cancer	2.85e-06	0.000219	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—NRAS—uterine cancer	2.84e-06	0.000218	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—PIK3CA—uterine cancer	2.83e-06	0.000218	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCL2—uterine cancer	2.82e-06	0.000217	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—PTEN—uterine cancer	2.82e-06	0.000217	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—NRAS—uterine cancer	2.82e-06	0.000217	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CTNNB1—uterine cancer	2.79e-06	0.000215	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—ERBB2—uterine cancer	2.78e-06	0.000214	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—MTHFR—uterine cancer	2.77e-06	0.000213	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CXCL8—uterine cancer	2.73e-06	0.00021	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PTEN—uterine cancer	2.72e-06	0.000209	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—EP300—uterine cancer	2.72e-06	0.000209	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—HRAS—uterine cancer	2.72e-06	0.000209	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—PIK3CA—uterine cancer	2.7e-06	0.000208	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—EP300—uterine cancer	2.69e-06	0.000207	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CDKN1B—uterine cancer	2.67e-06	0.000205	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—AKT1—uterine cancer	2.66e-06	0.000204	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—ERBB2—uterine cancer	2.65e-06	0.000204	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—AKT1—uterine cancer	2.64e-06	0.000203	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—PIK3CA—uterine cancer	2.64e-06	0.000203	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CXCL8—uterine cancer	2.64e-06	0.000203	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PTEN—uterine cancer	2.63e-06	0.000202	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCL2—uterine cancer	2.62e-06	0.000202	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—HRAS—uterine cancer	2.62e-06	0.000202	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—KRAS—uterine cancer	2.61e-06	0.000201	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—EP300—uterine cancer	2.6e-06	0.0002	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—AKT1—uterine cancer	2.59e-06	0.000199	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CDKN1B—uterine cancer	2.58e-06	0.000198	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—AKT1—uterine cancer	2.55e-06	0.000196	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CTNNB1—uterine cancer	2.52e-06	0.000194	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CXCL8—uterine cancer	2.51e-06	0.000193	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—EP300—uterine cancer	2.51e-06	0.000193	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—HRAS—uterine cancer	2.5e-06	0.000192	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—VEGFA—uterine cancer	2.46e-06	0.000189	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PTEN—uterine cancer	2.46e-06	0.000189	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CDKN1B—uterine cancer	2.45e-06	0.000189	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—PIK3CA—uterine cancer	2.45e-06	0.000189	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—KRAS—uterine cancer	2.44e-06	0.000188	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CTNNB1—uterine cancer	2.43e-06	0.000187	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—NRAS—uterine cancer	2.43e-06	0.000187	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—AKT1—uterine cancer	2.43e-06	0.000187	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—KRAS—uterine cancer	2.42e-06	0.000186	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—AKT1—uterine cancer	2.4e-06	0.000184	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—PIK3CA—uterine cancer	2.4e-06	0.000184	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PTEN—uterine cancer	2.37e-06	0.000182	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ERBB2—uterine cancer	2.35e-06	0.000181	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—EP300—uterine cancer	2.34e-06	0.00018	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CTNNB1—uterine cancer	2.32e-06	0.000178	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—AKT1—uterine cancer	2.31e-06	0.000178	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—EP300—uterine cancer	2.26e-06	0.000174	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PTEN—uterine cancer	2.26e-06	0.000174	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—PIK3CA—uterine cancer	2.24e-06	0.000173	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CXCL8—uterine cancer	2.23e-06	0.000172	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PTEN—uterine cancer	2.23e-06	0.000172	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—PIK3CA—uterine cancer	2.23e-06	0.000171	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—VEGFA—uterine cancer	2.22e-06	0.000171	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—HRAS—uterine cancer	2.22e-06	0.000171	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—AKT1—uterine cancer	2.2e-06	0.00017	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—NRAS—uterine cancer	2.19e-06	0.000169	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ERBB2—uterine cancer	2.19e-06	0.000168	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CDKN1B—uterine cancer	2.18e-06	0.000168	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TP53—uterine cancer	2.17e-06	0.000167	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—AKT1—uterine cancer	2.16e-06	0.000166	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—EP300—uterine cancer	2.16e-06	0.000166	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—VEGFA—uterine cancer	2.14e-06	0.000165	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—EP300—uterine cancer	2.13e-06	0.000164	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—NRAS—uterine cancer	2.12e-06	0.000163	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—KRAS—uterine cancer	2.09e-06	0.000161	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—HRAS—uterine cancer	2.08e-06	0.00016	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CXCL8—uterine cancer	2.07e-06	0.000159	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—HRAS—uterine cancer	2.06e-06	0.000158	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CTNNB1—uterine cancer	2.06e-06	0.000158	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—VEGFA—uterine cancer	2.04e-06	0.000157	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CDKN1B—uterine cancer	2.03e-06	0.000156	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—NRAS—uterine cancer	2.02e-06	0.000155	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—PIK3CA—uterine cancer	2.01e-06	0.000155	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PTEN—uterine cancer	2.01e-06	0.000154	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—AKT1—uterine cancer	2e-06	0.000154	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—PIK3CA—uterine cancer	1.99e-06	0.000153	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—AKT1—uterine cancer	1.96e-06	0.000151	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PTEN—uterine cancer	1.93e-06	0.000148	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PIK3CA—uterine cancer	1.92e-06	0.000148	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—EP300—uterine cancer	1.91e-06	0.000147	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CTNNB1—uterine cancer	1.91e-06	0.000147	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—KRAS—uterine cancer	1.89e-06	0.000145	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PTEN—uterine cancer	1.86e-06	0.000143	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TP53—uterine cancer	1.86e-06	0.000143	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PIK3CA—uterine cancer	1.86e-06	0.000143	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—EP300—uterine cancer	1.84e-06	0.000142	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—AKT1—uterine cancer	1.83e-06	0.000141	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—KRAS—uterine cancer	1.82e-06	0.00014	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—AKT1—uterine cancer	1.82e-06	0.00014	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—VEGFA—uterine cancer	1.81e-06	0.000139	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—NRAS—uterine cancer	1.79e-06	0.000138	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—EP300—uterine cancer	1.78e-06	0.000137	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—HRAS—uterine cancer	1.78e-06	0.000137	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—KRAS—uterine cancer	1.74e-06	0.000133	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PIK3CA—uterine cancer	1.73e-06	0.000133	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—VEGFA—uterine cancer	1.68e-06	0.00013	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TP53—uterine cancer	1.68e-06	0.000129	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PIK3CA—uterine cancer	1.67e-06	0.000129	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—NRAS—uterine cancer	1.66e-06	0.000128	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—AKT1—uterine cancer	1.64e-06	0.000126	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—AKT1—uterine cancer	1.63e-06	0.000125	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TP53—uterine cancer	1.62e-06	0.000125	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—HRAS—uterine cancer	1.6e-06	0.000123	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PIK3CA—uterine cancer	1.59e-06	0.000123	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PIK3CA—uterine cancer	1.57e-06	0.000121	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—AKT1—uterine cancer	1.57e-06	0.000121	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—HRAS—uterine cancer	1.55e-06	0.000119	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PTEN—uterine cancer	1.54e-06	0.000119	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TP53—uterine cancer	1.54e-06	0.000119	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—KRAS—uterine cancer	1.54e-06	0.000119	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—AKT1—uterine cancer	1.52e-06	0.000117	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—HRAS—uterine cancer	1.47e-06	0.000113	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—EP300—uterine cancer	1.47e-06	0.000113	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—KRAS—uterine cancer	1.43e-06	0.00011	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—AKT1—uterine cancer	1.42e-06	0.000109	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PIK3CA—uterine cancer	1.42e-06	0.000109	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TP53—uterine cancer	1.37e-06	0.000105	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—AKT1—uterine cancer	1.37e-06	0.000105	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PIK3CA—uterine cancer	1.36e-06	0.000105	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PIK3CA—uterine cancer	1.32e-06	0.000101	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—HRAS—uterine cancer	1.31e-06	0.000101	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—AKT1—uterine cancer	1.3e-06	0.0001	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—AKT1—uterine cancer	1.29e-06	9.88e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TP53—uterine cancer	1.27e-06	9.79e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HRAS—uterine cancer	1.22e-06	9.36e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—AKT1—uterine cancer	1.16e-06	8.9e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—AKT1—uterine cancer	1.11e-06	8.56e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PIK3CA—uterine cancer	1.09e-06	8.37e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—AKT1—uterine cancer	1.07e-06	8.27e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—AKT1—uterine cancer	8.89e-07	6.84e-05	CbGpPWpGaD
